|
GMFB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.07949999999624E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.372100E-04 |
| Normal-vs-Stage2 |
1.221640E-03 |
| Normal-vs-Stage3 |
1.824670E-04 |
| Normal-vs-Stage4 |
3.27980000003336E-06 |
| Stage1-vs-Stage2 |
7.307200E-01 |
| Stage1-vs-Stage3 |
5.949800E-01 |
| Stage1-vs-Stage4 |
1.007200E-01 |
| Stage2-vs-Stage3 |
9.631600E-01 |
| Stage2-vs-Stage4 |
3.003000E-01 |
| Stage3-vs-Stage4 |
2.671200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.99985000000069E-05 |
| Normal-vs-AfricanAmerican |
5.397800E-02 |
| Normal-vs-Asian |
1.356260E-03 |
| Caucasian-vs-AfricanAmerican |
3.573400E-01 |
| Caucasian-vs-Asian |
9.357400E-01 |
| AfricanAmerican-vs-Asian |
4.504200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.04809999999611E-05 |
| Normal-vs-Female |
6.4835999999957E-05 |
| Male-vs-Female |
1.553780E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.379200E-03 |
| Normal-vs-Age(41-60Yrs) |
8.70489999971191E-07 |
| Normal-vs-Age(61-80Yrs) |
4.82619999997436E-06 |
| Normal-vs-Age(81-100Yrs) |
6.870400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.072200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.250200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.699800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.262600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.006400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.787600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.864800E-01 |
| Classical-VS-Follicular |
7.540700E-03 |
| Classical-VS-Other |
2.427400E-01 |
| Classical-VS-Normal |
4.623100E-04 |
| Tall-VS-Follicular |
3.446100E-02 |
| Tall-VS-Other |
1.585820E-01 |
| Tall-VS-Normal |
7.680100E-02 |
| Follicular-VS-Other |
8.010400E-01 |
| Follicular-VS-Normal |
1.699499999952E-06 |
| Other-VS-Normal |
1.105830E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.55919999981158E-07 |
| Normal-vs-N1 |
1.198640E-04 |
| N0-vs-N1 |
8.671800E-01 |
|
|
